Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;31(2):240-241.
doi: 10.5021/ad.2019.31.2.240. Epub 2019 Feb 28.

Docetaxel-Aggravated Psoriasis

Seungkeol Yang  1 , Bo Ri Kim  1 , Chong Won Choi  1 , Sang Woong Youn  1
Affiliations

Docetaxel-Aggravated Psoriasis

Seungkeol Yang et al. Ann Dermatol. 2019 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: The authors have nothing to disclose.

Figures

Fig. 1
Fig. 1. Scaly erythematous plaques that appeared 3 days after the administration of docetaxel. We received the patient's consent form about publishing all photographic materials.
See this image and copyright information in PMC

References

    1. Sibaud V, Leboeuf NR, Roche H, Belum VR, Gladieff L, Deslandres M, et al. Dermatological adverse events with taxane chemotherapy. Eur J Dermatol. 2016;26:427–443. - PMC - PubMed
    1. Allende I, González-Hermosa R, Lázaro M, Díaz-Pérez JL. Psoriasis inducida por docetaxel [Docetaxel-induced psoriasis] Actas Dermosifiliogr. 2009;100:629–630. Spanish. - PubMed
    1. Kerob D, Le Maignan C, Vignon-Pennamen MD, Lebbe C. Psoriasis induit par le docétaxel [Docetaxel-induced psoriasis] Ann Dermatol Venereol. 2010;137:738–740. French. - PubMed
    1. Poi MJ, Berger M, Lustberg M, Layman R, Shapiro CL, Ramaswamy B, et al. Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review. Support Care Cancer. 2013;21:2679–2686. - PMC - PubMed
    1. Kodumudi KN, Woan K, Gilvary DL, Sahakian E, Wei S, Djeu JY. A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. Clin Cancer Res. 2010;16:4583–4594. - PMC - PubMed